Skip to content

to compare improvement on transcranial Direct Current Stimulation and repetitive Transcranial magnetic stimulation in patients of anxiety

A naturalistic comparative study of transcranial direct current stimulation and repetitive transcranial magnetic stimulation in the management of Generalized Anxiety Disorder. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076274
Enrollment
46
Registered
2024-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: comparative study of Transcranial Direct Current Stimulation and repetitive Transcranial Magnetic Stimulation in patients of anxiety disorder: To compare efficacy of add on transcranial

Sponsors

King Georges Medical University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Informed consent to participate in the study. Patients of Generalized anxiety disorder diagnosed as per DSM-5 should be on standard treatment from past six weeks to six months. Patient with GAD7 Anxiety score greater or equal to 10

Exclusion criteria

Exclusion criteria: Any medical comorbidity that can cause anxiety or requiring priority management. 2. Any contraindication to tDCS or rTMS. 3. Any other psychiatric comorbidity (except tobacco use disorder and other anxiety disorders- Panic disorder, Social Anxiety Disorder, Agoraphobia and other phobias)

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy and safety of add on tDCS to standard treatment in Generalized anxiety disorder. 2.To evaluate the efficacy and safety of add on rTMS to standard treatment in Generalized anxiety disorder. Timepoint: The outcome will be assessed at baseline, 1 week, 2 weeks and 4 weeks

Secondary

MeasureTime frame
To compare the efficacy and side effects of above both groupsTimepoint: at baseline, after 1 week, 2 weeks and 4 weeks

Countries

India

Contacts

Public ContactDr Sujit Kumar Kar

King Georges Medical University Lucknow

drsujita@gmail.com9956273747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026